-PTI NEW DELHI: Milk will be costlier in Delhi- NCR market with leading supplier Amul deciding to increase the rates by Rs 2 per litre effective from Tuesday. "We have decided to raise the milk price in Delhi-NCR region by Rs 2 per litre. The prices have been hiked after 13 months as input cost have increased," R S Sodhi, the Managing Director of Gujarat Cooperative Milk marketing Federation (GCMMF), which...
More »SEARCH RESULT
Total Matching Records found : 1516
In the ‘pharmacy of the world’ -PT Jyothi Datta
-The Hindu Business Line From maker of versions of drugs, India's pharmaceutical industry has turned a top innovator Twenty years ago, Ranbaxy was a home-spun drug-maker. The Indian Patents Act allowed companies to make chemically-similar versions of innovative drugs. Visionaries in the pharmaceutical sector, like Parvinder Singh (Ranbaxy's key architect and member of its promoter family) and Anji Reddy (founder of Dr Reddy's Laboratories), were alive. And the pharmaceutical industry did not have...
More »Bacteria are becoming bolder-Dr. Bala Ramachandran
-The Hindu Antibiotics are often used as an excuse for poor infection control Arjun (name changed) is an 8-year-old boy who was being treated for breathing difficulty in a hospital in one of the southern cities. He had suffered on and off with cough/cold since infancy and had been treated multiple times with antibiotics. His parents were not highly educated and hoped that he would get better as he grew older. This...
More »House panel: Government clearing harmful drugs -Rupali Mukherjee
-The Times of India MUMBAI: You could be popping certain pills and combinations that are illegally approved, harmful, cleared without proper clinical trials or even banned in the US and other countries. Delivering a severe rap on the government's knuckles, a parliamentary standing committee on health has charged it with "dilly-dallying and procrastination'' over serious irregularities in approval of life-saving medicines, not following the global ban on harmful drugs, and failing...
More »The Cost of Drugs: Beyond the Supreme Court Order -Sanjay Nagral
-Economic and Political Weekly While the Supreme Court decision in the recent Novartis case has cleared the way for production of generic drugs in India, doctors have to prescribe cheaper alternatives to costly brands if patients with limited means are to benefit. What is being hailed as a victory in the struggle for affordable medicines in the country will actually be one only when there is a pro-patient slant to the...
More »
